MWNA
Marshall Wace North America Portfolio holdings
AUM
$23.3B
This Quarter Return
+8.9%
1 Year Return
+46.22%
3 Year Return
+108.24%
5 Year Return
–
10 Year Return
–
AUM
$14.6B
AUM Growth
+$14.6B
(-17%)
Cap. Flow
-$4.02B
Cap. Flow
% of AUM
-27.6%
Top 10 Holdings %
Top 10 Hldgs %
20.74%
Holding
1,653
New
314
Increased
216
Reduced
349
Closed
768
Top Buys
| 1 |
Alphabet (Google) Class A
GOOGL
|
$213M |
| 2 |
Medtronic
MDT
|
$130M |
| 3 |
Charter Communications
CHTR
|
$105M |
| 4 |
Merck
MRK
|
$99.9M |
| 5 |
ABMD
Abiomed Inc
ABMD
|
$96.5M |
Top Sells
| 1 |
Meta Platforms (Facebook)
META
|
$230M |
| 2 |
Baidu
BIDU
|
$120M |
| 3 |
Vertex Pharmaceuticals
VRTX
|
$112M |
| 4 |
Constellation Brands
STZ
|
$111M |
| 5 |
Abbott
ABT
|
$110M |
Sector Composition
| 1 | Healthcare | 31.1% |
| 2 | Technology | 16.39% |
| 3 | Industrials | 11.22% |
| 4 | Consumer Discretionary | 9.86% |
| 5 | Financials | 9.1% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
Biogen
BIIB
$20.7B
| $73.1M | 0.5% |
+206,768
| New | +$73.1M |
|
|
TWOU
52
DELISTED
2U, Inc.
TWOU
| $71.7M | 0.49% |
953,485
-174,734
| -15% | -$13.1M |
|
53
T-Mobile US
TMUS
$284B
| $70.8M | 0.49% |
1,008,217
+272,139
| +37% | +$19.1M |
|
54
Gilead Sciences
GILD
$140B
| $70M | 0.48% |
+906,920
| New | +$70M |
|
55
Apple
AAPL
$3.53T
| $69.6M | 0.48% |
308,355
-29,531
| -9% | -$6.67M |
|
56
JPMorgan Chase
JPM
$818B
| $69.2M | 0.48% |
613,062
+163,688
| +36% | +$18.5M |
|
|
SAGE
57
DELISTED
Sage Therapeutics
SAGE
| $69.1M | 0.47% |
489,148
-38,468
| -7% | -$5.43M |
|
58
Ollie's Bargain Outlet
OLLI
$7.95B
| $67.9M | 0.47% |
707,041
| – | – |
|
|
RTN
59
DELISTED
Raytheon Company
RTN
| $63.8M | 0.44% |
308,931
+240,981
| +355% | +$49.8M |
|
60
CVS Health
CVS
$92.7B
| $61.7M | 0.42% |
783,805
+199,376
| +34% | +$15.7M |
|
61
Thomson Reuters
TRI
$79.9B
| $60.3M | 0.41% |
+1,320,197
| New | +$60.3M |
|
62
Progressive
PGR
$144B
| $59.9M | 0.41% |
843,284
-33,995
| -4% | -$2.42M |
|
63
Neurocrine Biosciences
NBIX
$13.7B
| $58.5M | 0.4% |
475,440
-127,535
| -21% | -$15.7M |
|
64
Cencora
COR
$56.9B
| $57.2M | 0.39% |
620,403
+454,154
| +273% | +$41.9M |
|
65
Boeing
BA
$175B
| $56.7M | 0.39% |
152,565
+115,963
| +317% | +$43.1M |
|
|
ALXN
66
DELISTED
Alexion Pharmaceuticals Inc
ALXN
| $55.5M | 0.38% |
399,292
-605,877
| -60% | -$84.2M |
|
|
AGN
67
DELISTED
Allergan plc
AGN
| $55.5M | 0.38% |
291,146
+179,280
| +160% | +$34.1M |
|
68
Broadcom
AVGO
$1.42T
| $55.3M | 0.38% |
224,229
-111,518
| -33% | -$27.5M |
|
69
RTX Corp
RTX
$211B
| $54.9M | 0.38% |
392,739
-9,779
| -2% | -$1.37M |
|
70
Intuit
INTU
$185B
| $54.6M | 0.38% |
240,146
-51,063
| -18% | -$11.6M |
|
71
TSMC
TSM
$1.2T
| $54.2M | 0.37% |
1,228,073
+70,473
| +6% | +$3.11M |
|
|
PX
72
DELISTED
Praxair Inc
PX
| $53.9M | 0.37% |
335,557
-124,763
| -27% | -$20.1M |
|
73
BioMarin Pharmaceuticals
BMRN
$11.3B
| $53.8M | 0.37% |
555,209
+257,073
| +86% | +$24.9M |
|
74
Universal Health Services
UHS
$11.5B
| $53.1M | 0.36% |
415,588
-145,395
| -26% | -$18.6M |
|
75
Rollins
ROL
$27.2B
| $51.9M | 0.36% |
+854,390
| New | +$51.9M |
|